These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 34409904)

  • 1. Metrological properties of neuropsychological tests for measuring cognitive change in individuals with prodromal Alzheimer's disease.
    Zhang X; Wu Y; He Y; Ge X; Cui J; Han H; Luo Y; Liu L; Wang Z; Yu H;
    Aging Ment Health; 2022 Oct; 26(10):1988-1996. PubMed ID: 34409904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting conversion of patients with Mild Cognitive Impairment to Alzheimer's disease using bedside cognitive assessments.
    Clarke A; Ashe C; Jenkinson J; Rowe O; A D N I ; Hyland P; Commins S
    J Clin Exp Neuropsychol; 2022 Dec; 44(10):703-712. PubMed ID: 36803664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal Exposure-Response Modeling of Multiple Indicators of Alzheimer's Disease Progression.
    Polhamus DG; Dolton MJ; Rogers JA; Honigberg L; Jin JY; Quartino A
    J Prev Alzheimers Dis; 2023; 10(2):212-222. PubMed ID: 36946448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bayesian estimation for the accuracy of three neuropsychological tests in detecting Alzheimer's disease and mild cognitive impairment: a retrospective analysis of the ADNI database.
    Wang X; Li F; Tian J; Gao Q; Zhu H
    Eur J Med Res; 2023 Oct; 28(1):427. PubMed ID: 37821912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychometric Properties of the Clinical Dementia Rating - Sum of Boxes and Other Cognitive and Functional Outcomes in a Prodromal Alzheimer's Disease Population.
    McDougall F; Edgar C; Mertes M; Delmar P; Fontoura P; Abi-Saab D; Lansdall CJ; Boada M; Doody R
    J Prev Alzheimers Dis; 2021; 8(2):151-160. PubMed ID: 33569561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between the Montreal Cognitive Assessment and Mini-mental State Examination for assessment of mild cognitive impairment in older adults.
    Trzepacz PT; Hochstetler H; Wang S; Walker B; Saykin AJ;
    BMC Geriatr; 2015 Sep; 15():107. PubMed ID: 26346644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease.
    Besser LM; Litvan I; Monsell SE; Mock C; Weintraub S; Zhou XH; Kukull W
    Parkinsonism Relat Disord; 2016 Jun; 27():54-60. PubMed ID: 27089852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimal clinically important difference in Alzheimer's disease: Rapid review.
    Muir RT; Hill MD; Black SE; Smith EE
    Alzheimers Dement; 2024 May; 20(5):3352-3363. PubMed ID: 38561021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting Alzheimer's disease based on survival data and longitudinally measured performance on cognitive and functional scales.
    Wu Y; Zhang X; He Y; Cui J; Ge X; Han H; Luo Y; Liu L; Wang X; Yu H;
    Psychiatry Res; 2020 Sep; 291():113201. PubMed ID: 32559670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of White Matter Hyperintensities with Cognitive Decline: A Longitudinal Study.
    Wang YL; Chen W; Cai WJ; Hu H; Xu W; Wang ZT; Cao XP; Tan L; Yu JT;
    J Alzheimers Dis; 2020; 73(2):759-768. PubMed ID: 31839612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simplifying Alzheimer's Disease Monitoring: A Novel Machine-Learning Approach to Estimate the Clinical Dementia Rating Sum of Box Changes Using the Mini-Mental State Examination and Functional Activities Questionnaire.
    Sato K; Niimi Y; Ihara R; Suzuki K; Iwata A; Iwatsubo T; ;
    J Alzheimers Dis; 2024; 99(3):953-963. PubMed ID: 38759009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classification, Prediction, and Concordance of Cognitive and Functional Progression in Patients with Mild Cognitive Impairment in the United States: A Latent Class Analysis.
    Mouchet J; Betts KA; Georgieva MV; Ionescu-Ittu R; Butler LM; Teitsma X; Delmar P; Kulalert T; Zhu J; Lema N; Desai U
    J Alzheimers Dis; 2021; 82(4):1667-1682. PubMed ID: 34219723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Research on predicting the risk of mild cognitive impairment in the elderly based on the joint model].
    Xu J; Yuan MQ; Fang Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Feb; 43(2):269-276. PubMed ID: 35184495
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of intensive lifestyle changes on the progression of mild cognitive impairment or early dementia due to Alzheimer's disease: a randomized, controlled clinical trial.
    Ornish D; Madison C; Kivipelto M; Kemp C; McCulloch CE; Galasko D; Artz J; Rentz D; Lin J; Norman K; Ornish A; Tranter S; DeLamarter N; Wingers N; Richling C; Kaddurah-Daouk R; Knight R; McDonald D; Patel L; Verdin E; E Tanzi R; Arnold SE
    Alzheimers Res Ther; 2024 Jun; 16(1):122. PubMed ID: 38849944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visual Evaluation of Medial Temporal Lobe Atrophy as a Clinical Marker of Conversion from Mild Cognitive Impairment to Dementia and for Predicting Progression in Patients with Mild Cognitive Impairment and Mild Alzheimer's Disease.
    Persson K; Barca ML; Eldholm RS; Cavallin L; Šaltytė Benth J; Selbæk G; Brækhus A; Saltvedt I; Engedal K
    Dement Geriatr Cogn Disord; 2017; 44(1-2):12-24. PubMed ID: 28614836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring cognitive change in subjects with prodromal Alzheimer's disease.
    Mura T; Proust-Lima C; Jacqmin-Gadda H; Akbaraly TN; Touchon J; Dubois B; Berr C
    J Neurol Neurosurg Psychiatry; 2014 Apr; 85(4):363-70. PubMed ID: 23840054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detecting Treatment Group Differences in Alzheimer's Disease Clinical Trials: A Comparison of Alzheimer's Disease Assessment Scale - Cognitive Subscale (ADAS-Cog) and the Clinical Dementia Rating - Sum of Boxes (CDR-SB).
    Wessels AM; Dowsett SA; Sims JR
    J Prev Alzheimers Dis; 2018; 5(1):15-20. PubMed ID: 29405227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of MRI-visible perivascular spaces with longitudinal cognitive decline across the Alzheimer's disease spectrum.
    Wang ML; Zou QQ; Sun Z; Wei XE; Li PY; Wu X; Li YH;
    Alzheimers Res Ther; 2022 Dec; 14(1):185. PubMed ID: 36514127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychometric Evaluation of the Neuropsychological Test Battery in Individuals with Normal Cognition, Mild Cognitive Impairment, or Mild to Moderate Alzheimer's Disease: Results from a Longitudinal Study.
    Harrison JE; Rentz DM; Brashear HR; Arrighi HM; Ropacki MT; Liu E
    J Prev Alzheimers Dis; 2018; 5(4):236-244. PubMed ID: 30298182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between "Brain-Age Score" (BAS) and traditional neuropsychological screening tools in Alzheimer's disease.
    Beheshti I; Maikusa N; Matsuda H
    Brain Behav; 2018 Aug; 8(8):e01020. PubMed ID: 29931756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.